NCBiotech brings together partners and implements programs that stimulate growth in the life sciences statewide. Below are the impact areas and targeted outcomes for our 2030 strategy to further ...

“The KickStart Grant Awards help de-risk these technologies by establishing a collaboration agreement between the startup ...

Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...

Redbud has introduced its microfluidics sample prep platform, called Redbud NA1, for use in research and surveillance for ...

The BRITE program and its partnerships with local universities provided Udemadu with critical hands-on training in cell culture and lab techniques. This provided a strong foundation that made his ...

Two pharmaceutical companies with operations in North Carolina are joining forces for a greater impact on women’s health. Cosette Pharmaceuticals, based in Bridgewater, N.J., with a pharmaceutical ...

The University of North Carolina at Chapel Hill’s KickStart Commercialization Grant program hosted a luncheon last month to celebrate seven innovative startups awarded a combined $326,000 from the ...

Claradele Pharmaceuticals, a Greenville startup developing a unique immunotherapy for metastatic melanoma, is the 2024 NCBiotech Venture Challenge winner. The Claradele selection marked the pinnacle ...

Join Culture Biosciences for a dynamic and interactive event where you'll learn valuable insights on driving upstream process development innovation. Industry experts will share their insights and ...

Flourish Research, a multi-site clinical trials company based in Apex, has acquired a California clinical research facility.

Veterans and military members transitioning out of their time in service have skills and experiences that many employers are searching for. Life sciences companies have world-class manufacturing ...

Drug contract development and manufacturing company Catalent Inc., with operations in the Triangle and Greenville, is expected to become a part of Novo Holdings by the end of 2024 in a $16.5 billion ...